The Beauty Health Company (NASDAQ: SKIN) reported Q4 EPS of ($0.08), $0.03 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $83.5 million versus the consensus estimate of $77.39 million.

For earnings history and earnings-related data on The Beauty Health Company (SKIN) click here.